Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeWidexWIDEX Pure Sound Technology: New New Breakthrough Technology Reproduces Natural Sound in...

WIDEX Pure Sound Technology: New New Breakthrough Technology Reproduces Natural Sound in Hearing Aids

February 2, 2021

Widex PureSound technology, available for the first time in its new flagship WIDEX MOMENT™ hearing aids, features two distinct signal processing pathways — a “classic” version and a new ZeroDelay™ Accelerator pathway that dramatically changes how hearing aids sound.

“Sound quality and the ‘naturalness’ of sound remain among the most-cited reasons people don’t pursue hearing assistance, despite the great strides in hearing aid innovation made over the last decades,” said Widex Head of Audiology Lise Henningsen. “When hearing aids went digital, drastic improvements in noise reduction and advanced signal processing came at a price, but Widex has figured out how to overcome it.”

Taking an analog sound wave, converting it to a digital signal, processing it, then re-converting into a sound wave takes anywhere from 4 to 8 milliseconds. Studies have shown that a processing delay of that length can adversely affect sound quality, especially if processed sound and unprocessed sound mix in the ear canal of a hearing aid user, creating what is called a comb filter effect.

“When that happens, the perceived quality of the user’s own voice becomes tinny and artificial,” Henningsen said. “Environmental sounds come out distorted and unusual and, overall, the resulting sound becomes strenuous to listen to over time.”

The new Widex ZeroDelay Accelerator reduces the processing delay in WIDEX MOMENT hearing aids to below 0.5 milliseconds — a remarkable technological feat considering Widex already leads the industry with the lowest system delay through its “classic” processing pathway. The company’s unique, legacy time domain filter bank, 32kHz sampling rate, and 16kHz digital bandwidth create very high-fidelity sound across its family of hearing aids, with a processing delay under 3 milliseconds.

For the second, accelerated pathway in Widex PureSound-based hearing aids, signal processing is adapted to the ZeroDelay design to deliver the purest sound quality. Core functions, such as acoustics stability, adaptive gain control, and enhanced signal-to-noise ratio, continue to take priority, while others are modified for the faster ZeroDelay pathway. The two pathways — ZeroDelay and “classic” — exist side-by-side on the Widex PureSound platform. Depending on the needs of the wearer, a hearing care professional can program one or the other as the default mode. From there, the PureSound platform is adaptable to each user’s situation and preferred hearing experience.

“The wearer of hearing aids with the two distinct pathways can switch between them based on where they are and what they want to hear, thereby enjoying far greater sound quality and a more natural experience in most situations,” said Henningsen. Other information here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy